Literature DB >> 29679567

HDAC-mediated deacetylation of KLF5 associates with its proteasomal degradation.

Ran Tao1, Baotong Zhang2, Yixiang Li2, Jamie L King2, Ruoyu Tian3, Siyuan Xia2, Cara Rae Schiavon2, Jin-Tang Dong4.   

Abstract

Krüppel-like factor 5 (KLF5) is a basic transcription factor that regulates diverse cellular processes during tumor development. Acetylation of KLF5 at lysine 369 (K369) reverses its function from promoting to suppressing cell proliferation and tumor growth. In this study, we examined the regulation of KLF5 by histone deacetylases in the prostate cancer cell line DU 145. While confirming the functions of HDAC1/2 in KLF5 deacetylation and the promotion of cell proliferation, we found that the knockdown of HDAC1/2 upregulated KLF5 protein but not KLF5 mRNA, and the increase in KLF5 protein level by silencing HDAC1/2 was at least in part due to decreased proteasomal degradation. Deacetylase activity was required for HDAC1/2-mediated KLF5 degradation, and mutation of KLF5 to an acetylation-mimicking form prevented its degradation, even though the mutation did not affect the binding of KLF5 with HDAC1/2. Mutation of K369 to arginine, which prevents acetylation, did not affect the binding of KLF5 to HDAC1 or the response of KLF5 to HDAC1/2-promoted degradation. These findings provide a novel mechanistic association between the acetylation status of KLF5 and its protein stability. They also suggest that maintaining KLF5 in a deacetylated form may be an important mechanism by which KLF5 and HDACs promote cell proliferation and tumor growth. Published by Elsevier Inc.

Entities:  

Keywords:  Acetylation; Histone deacetylases (HDACs); KLF5; Protein stability

Mesh:

Substances:

Year:  2018        PMID: 29679567      PMCID: PMC5940529          DOI: 10.1016/j.bbrc.2018.04.153

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain.

Authors:  Saku Miyamoto; Toru Suzuki; Shinsuke Muto; Kenichi Aizawa; Akatsuki Kimura; Yoshiko Mizuno; Tomoko Nagino; Yasushi Imai; Naruhiko Adachi; Masami Horikoshi; Ryozo Nagai
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

2.  KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells.

Authors:  Baotong Zhang; Zhiqian Zhang; Siyuan Xia; Changsheng Xing; Xinpei Ci; Xin Li; Ranran Zhao; Sha Tian; Gui Ma; Zhengmao Zhu; Liya Fu; Jin-Tang Dong
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

3.  The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.

Authors:  Dong Zhao; Han-Qiu Zheng; Zhongmei Zhou; Ceshi Chen
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

4.  The deacetylase HDAC1 negatively regulates the cardiovascular transcription factor Krüppel-like factor 5 through direct interaction.

Authors:  Takayoshi Matsumura; Toru Suzuki; Kenichi Aizawa; Yoshiko Munemasa; Shinsuke Muto; Masami Horikoshi; Ryozo Nagai
Journal:  J Biol Chem       Date:  2005-01-24       Impact factor: 5.157

5.  The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.

Authors:  Gordin Zupkovitz; Reinhard Grausenburger; Reinhard Brunmeir; Silvia Senese; Julia Tischler; Jennifer Jurkin; Martina Rembold; Dominique Meunier; Gerda Egger; Sabine Lagger; Susanna Chiocca; Fritz Propst; Georg Weitzer; Christian Seiser
Journal:  Mol Cell Biol       Date:  2009-12-22       Impact factor: 4.272

6.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

Review 7.  Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.

Authors:  Jin-Tang Dong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

8.  Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification.

Authors:  Peng Guo; Xue-Yuan Dong; Xiaohui Zhang; Ke-Wen Zhao; Xiaodong Sun; Qunna Li; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2008-12-04       Impact factor: 5.157

9.  KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression.

Authors:  Z Dong; L Yang; D Lai
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

10.  Opposing effects of KLF5 on the transcription of MYC in epithelial proliferation in the context of transforming growth factor beta.

Authors:  Peng Guo; Xue-Yuan Dong; Kewen Zhao; Xiaodong Sun; Qunna Li; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2009-08-14       Impact factor: 5.157

View more
  5 in total

1.  TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.

Authors:  Yixiang Li; Baotong Zhang; Lingwei Xiang; Siyuan Xia; Omer Kucuk; Xingming Deng; Lawrence H Boise; Jin-Tang Dong
Journal:  Theranostics       Date:  2020-06-18       Impact factor: 11.556

2.  ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.

Authors:  Xinmiao Yu; Minghao Wang; Jingjing Wu; Qiang Han; Xiupeng Zhang
Journal:  J Exp Clin Cancer Res       Date:  2019-01-28

3.  Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.

Authors:  Baotong Zhang; Yixiang Li; Qiao Wu; Lin Xie; Benjamin Barwick; Changying Fu; Xin Li; Daqing Wu; Siyuan Xia; Jing Chen; Wei Ping Qian; Lily Yang; Adeboye O Osunkoya; Lawrence Boise; Paula M Vertino; Yichao Zhao; Menglin Li; Hsiao-Rong Chen; Jeanne Kowalski; Omer Kucuk; Wei Zhou; Jin-Tang Dong
Journal:  Nat Commun       Date:  2021-03-17       Impact factor: 14.919

4.  Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer.

Authors:  Yanjie Kong; Wenlong Ren; Huan Fang; Naseer Ali Shah; Yujie Shi; Dingyun You; Chengang Zhou; Dewei Jiang; Chuanyu Yang; Huichun Liang; Wenjin Liu; Luzhen Wang; Wenqiang Gan; Xing Wan; Fubing Li; Zhen Li; Ceshi Chen; Ni Xie
Journal:  Int J Biol Sci       Date:  2022-02-28       Impact factor: 6.580

Review 5.  The Partial Role of KLF4 and KLF5 in Gastrointestinal Tumors.

Authors:  Jun-Chen Li; Qiu-Han Chen; Rui Jian; Jiang-Rong Zhou; Yun Xu; Fang Lu; Jun-Qiao Li; Hao Zhang
Journal:  Gastroenterol Res Pract       Date:  2021-07-27       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.